Bodal Chemicals Limited

NSE:BODALCHEM.NS

86.51 (INR) • At close September 16, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) INR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 13,946.2115,742.820,267.8412,209.2913,617.0913,988.4911,302.6612,362.979,099.5510,358.0489,595.1615,295.8926,137.065,596.0974,675.453,954.8624,048.8392,541.741,468.13
Cost of Revenue 8,627.469,038.4214,847.538,917.729,895.319,878.987,868.377,973.245,705.6837,527.4996,932.4633,745.4765,284.9814,449.3433,226.5253,063.2563,160.1122,019.7831,148.963
Gross Profit 5,318.756,704.385,420.313,291.573,721.784,109.513,434.294,389.733,393.8672,830.5492,662.6981,550.416852.0791,146.7541,448.925891.606888.727521.957319.167
Gross Profit Ratio 0.3810.4260.2670.270.2730.2940.3040.3550.3730.2730.2780.2930.1390.2050.310.2250.220.2050.217
Reseach & Development Expenses 044.1349.4840.1336.2129.5520.6418.9115.710000000000
General & Administrative Expenses 0120.19146.02115.52104.1547.4340.1336.3225.709121.17134.736808.598166.912111.84974.04248.81337.74924.06918.578
Selling & Marketing Expenses 093.25212.7490.45145.53118.8898.586.5987.601373.446259.773217.798310.221277.394231.902160.942172.0496.54173.322
SG&A 4,816.84213.44358.76205.97249.68166.31138.63122.91113.31494.616394.5091,026.396477.133389.243305.942409.755209.789120.6191.9
Other Expenses 248.02116.135.455.3237.0520.712.652,288.661,907.541714.006631.059474.1927.3441.011735.77520.267321.57237.027163.899
Operating Expenses 4,816.845,901.93,626.562,513.332,506.871,922.921,584.212,411.572,020.8511,208.6221,025.5681,500.588979.192677.9151,041.712930.022531.359357.637255.799
Operating Income 501.91850.221,795.83776.921,210.422,174.541,850.081,998.921,305.2571,392.262465.932-330.642-127.113467.678405.99-39.639356.786163.77362.845
Operating Income Ratio 0.0360.0540.0890.0640.0890.1550.1640.1620.1430.1340.049-0.062-0.0210.0840.087-0.010.0880.0640.043
Total Other Income Expenses Net -454.64-341.86-375.38-223.08-204.068.3214.720.76-67.759-229.665-1,171.198-380.47-281.009-217.527-203.111-131.551-90.27-34.233-14.706
Income Before Tax 47.27508.361,420.45553.841,012.192,191.71,864.781,998.921,305.2571,392.262465.932-330.642-408.122251.312204.102-169.967267.098130.08748.662
Income Before Tax Ratio 0.0030.0320.070.0450.0740.1570.1650.1620.1430.1340.049-0.062-0.0670.0450.044-0.0430.0660.0510.033
Income Tax Expense -17.42128.03433.82156.17146.02769.87618.87712.46445.391474.438164.304-97.388-109.782125.95669.465-58.60792.59818.38624.299
Net Income 64.69380.331,042.28419.82871.641,431.991,225.61,285.84859.866917.824301.628-232.4298.34175.387134.637-111.36174.5111.70124.362
Net Income Ratio 0.0050.0240.0510.0340.0640.1020.1080.1040.0940.0890.031-0.0440.0490.0310.029-0.0280.0430.0440.017
EPS 0.513.038.793.437.1311.7210.6712.187.888.412.76-2.13-2.881.681.35-1.422.382.060.34
EPS Diluted 0.513.038.793.437.1311.7110.6712.187.888.412.76-2.13-2.881.421.35-1.412.382.060.34
EBITDA 1,106.831,449.532,301.451,145.261,477.422,465.832,020.552,292.841,582.4411,840.3742,604.557202.44848.874612.231529.68946.116421.152203.588100.372
EBITDA Ratio 0.0790.0920.1140.0940.1080.1760.1790.1850.1740.1780.2710.0380.0080.1090.1130.0120.1040.080.068